Doxorubicin induced immune abnormalities and inflammatory responses via HMGB1, HIF1-α and VEGF pathway in progressive of cardiovascular damage

BACKGROUND: Doxorubicin (DOX) is a commonly used treatment for cancer and the mechanism of DOX-induced cardiomyocyte damage in cardiovascular disease is not fully understood. High-mobility group box 1 (HMGB1), strong induce proinflammatory cytokines via damage associated molecular pattern (DAMP) whi...

Descripción completa

Detalles Bibliográficos
Autores principales: Syukri, Ahmad, Budu, Hatta, Mochammad, Amir, Muzakkir, Rohman, Mohammad Saifur, Mappangara, Idar, Kaelan, Cahyono, Wahyuni, Siti, Bukhari, Agussalim, Junita, Ade Rifka, Primaguna, Muhammad Reza, Dwiyanti, Ressy, Febrianti, Andini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Systematic Review / Meta-analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943401/
https://www.ncbi.nlm.nih.gov/pubmed/35340325
http://dx.doi.org/10.1016/j.amsu.2022.103501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943401/
https://www.ncbi.nlm.nih.gov/pubmed/35340325
http://dx.doi.org/10.1016/j.amsu.2022.103501

Ejemplares similares